169 related articles for article (PubMed ID: 23989996)
21. Patient outcomes and surgical complications in coccidioidomycosis-related hydrocephalus: an institutional review.
Hardesty DA; Ramey W; Afrasiabi M; Beck B; Gonzalez O; Moran A; Nakaji P
J Neurosurg; 2014 Oct; 121(4):785-9. PubMed ID: 25061867
[TBL] [Abstract][Full Text] [Related]
22. Non-adjustable gravitational valves or adjustable valves in the treatment of hydrocephalus after aneurysmal subarachnoid hemorrhage patients?
Arts S; van Lieshout JH; van Bilsen M; Karadag C; Beez T; van den Abbeele L; Aquarius R; Vinke S; Bartels RHMA; van Lindert EJ; Hänggi D; Boogaarts HD
Acta Neurochir (Wien); 2022 Nov; 164(11):2867-2873. PubMed ID: 36149501
[TBL] [Abstract][Full Text] [Related]
23. Congenital hydrocephalus and ventriculoperitoneal shunts: influence of etiology and programmable shunts on revisions.
Notarianni C; Vannemreddy P; Caldito G; Bollam P; Wylen E; Willis B; Nanda A
J Neurosurg Pediatr; 2009 Dec; 4(6):547-52. PubMed ID: 19951042
[TBL] [Abstract][Full Text] [Related]
24. CSF outflow resistance as predictor of shunt function. A long-term study.
Malm J; Lundkvist B; Eklund A; Koskinen LO; Kristensen B
Acta Neurol Scand; 2004 Sep; 110(3):154-60. PubMed ID: 15285771
[TBL] [Abstract][Full Text] [Related]
25. A randomized, controlled study of a programmable shunt valve versus a conventional valve for patients with hydrocephalus. Hakim-Medos Investigator Group.
Pollack IF; Albright AL; Adelson PD
Neurosurgery; 1999 Dec; 45(6):1399-408; discussion 1408-11. PubMed ID: 10598708
[TBL] [Abstract][Full Text] [Related]
26. Adjustable valves in normal-pressure hydrocephalus: a retrospective study of 218 patients.
Zemack G; Romner B
Neurosurgery; 2002 Dec; 51(6):1392-400; discussion 1400-2. PubMed ID: 12445344
[TBL] [Abstract][Full Text] [Related]
27. Adjustable vs set-pressure valves decrease the risk of proximal shunt obstruction in the treatment of pediatric hydrocephalus.
McGirt MJ; Buck DW; Sciubba D; Woodworth GF; Carson B; Weingart J; Jallo G
Childs Nerv Syst; 2007 Mar; 23(3):289-95. PubMed ID: 17106749
[TBL] [Abstract][Full Text] [Related]
28. The combination of a programmable valve and a subclavicular anti-gravity device in hydrocephalus patients at high risk for hygromas.
Zachenhofer I; Donat M; Roessler K
Neurol Res; 2012 Apr; 34(3):219-22. PubMed ID: 22333990
[TBL] [Abstract][Full Text] [Related]
29. Revision rates of flow- versus pressure-regulated ventricular shunt valves for the treatment of hydrocephalus in neonates following germinal matrix haemorrhage-a retrospective review.
Mulcahy T; Ma N
Childs Nerv Syst; 2023 Apr; 39(4):943-952. PubMed ID: 36538103
[TBL] [Abstract][Full Text] [Related]
30. Complications of endoscopic third ventriculostomy in previously shunted patients.
Hader WJ; Walker RL; Myles ST; Hamilton M
Neurosurgery; 2008 Jul; 63(1 Suppl 1):ONS168-74; discussion ONS174-5. PubMed ID: 18728596
[TBL] [Abstract][Full Text] [Related]
31. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients.
Ritz R; Roser F; Morgalla M; Dietz K; Tatagiba M; Will BE
BMC Infect Dis; 2007 May; 7():38. PubMed ID: 17488498
[TBL] [Abstract][Full Text] [Related]
32. Parent/guardian knowledge regarding implanted shunt type, setting, and symptoms of malfunction/infection.
Ackerman LL; Fulkerson DH; Jea A; Smith JL
J Neurosurg Pediatr; 2018 Apr; 21(4):359-366. PubMed ID: 29328006
[TBL] [Abstract][Full Text] [Related]
33. [The Codman Medos programmable shunt valve. Evaluation of 53 implantations in 50 patients].
Belliard H; Roux FX; Turak B; Nataf F; Devaux B; Cioloca C
Neurochirurgie; 1996; 42(3):139-45; discussion 145-6. PubMed ID: 9084740
[TBL] [Abstract][Full Text] [Related]
34. The Medos Hakim programmable valve in the treatment of pediatric hydrocephalus.
Reinprecht A; Dietrich W; Bertalanffy A; Czech T
Childs Nerv Syst; 1997; 13(11-12):588-93; discussion 593-4. PubMed ID: 9454974
[TBL] [Abstract][Full Text] [Related]
35. Prevention of ventricular catheter obstruction and slit ventricle syndrome by the prophylactic use of the Integra antisiphon device in shunt therapy for pediatric hypertensive hydrocephalus: a 25-year follow-up study.
Gruber RW; Roehrig B
J Neurosurg Pediatr; 2010 Jan; 5(1):4-16. PubMed ID: 20043731
[TBL] [Abstract][Full Text] [Related]
36. Comparison Between Flow-Regulated and Gravitational Shunt Valves in the Treatment of Normal Pressure Hydrocephalus: Flow-Grav Study.
Scheffler P; Oertel MF; Stieglitz LH
Neurosurgery; 2021 Aug; 89(3):413-419. PubMed ID: 34131760
[TBL] [Abstract][Full Text] [Related]
37. Morbidity of ventricular cerebrospinal fluid shunt surgery in adults: an 8-year study.
Korinek AM; Fulla-Oller L; Boch AL; Golmard JL; Hadiji B; Puybasset L
Neurosurgery; 2011 Apr; 68(4):985-94; discussion 994-5. PubMed ID: 21221037
[TBL] [Abstract][Full Text] [Related]
38. Gravity-assisted valve (GAV) systems to prevent low-pressure headaches in patients with lumboperitoneal shunts.
Hussain MA; Strachan RD
Br J Neurosurg; 2017 Aug; 31(4):426-429. PubMed ID: 28165764
[TBL] [Abstract][Full Text] [Related]
39. Use of the proGAV shunt valve in normal-pressure hydrocephalus.
Toma AK; Tarnaris A; Kitchen ND; Watkins LD
Neurosurgery; 2011 Jun; 68(2 Suppl Operative):245-9. PubMed ID: 21368692
[TBL] [Abstract][Full Text] [Related]
40. Initial proximal obstruction of ventriculoperitoneal shunt in patients with preterm-related posthaemorrhagic hydrocephalus.
Miranda P; Simal JA; Menor F; Plaza E; Conde R; Botella C
Pediatr Neurosurg; 2011; 47(2):88-92. PubMed ID: 21952534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
